Raburn Mallory, MD

Dr. Mallory is senior vice president, head of clinical development, with leadership responsibility for the clinical development organization and strategic direction of vaccine life-cycle management. He plays a key role in Novavax’ regulatory filings, including the synthesis of clinical data across Novavax’ COVID-19 clinical studies and engagement with global regulatory agencies. Prior to joining the company in 2020, he was Vice President of Clinical Development and the Global Clinical Lead for the COVID-19 and influenza vaccines at AstraZeneca. Earlier, he was a Robert Wood Johnson Clinical Scholar at Johns Hopkins University. Dr. Mallory earned his medical degree from Yale University School Medicine and undergraduate degree from Brown University.